New Ingredients, New Life For Cytodyne’s Weight Loss Supplements
This article was originally published in The Tan Sheet
A firm that has agreed to pay as much as $12.8 million to settle a false advertising complaint and that reorganized under bankruptcy protection after incurring losses from ephedra-related lawsuits is returning to the marketplace with a new weight loss supplement, according to a Jan. 15 announcement
You may also be interested in...
Challenges to the risk-benefit analysis FDA applied in banning the use of ephedra will continue following the Supreme Court's May 14 refusal to hear Nutraceutical Corp.'s appeal, according to the firm's attorney and to industry trade groups
Bayer "went too far" with weight-loss and -control claims for its One-A-Day WeightSmart product and violated a 1991 sanction the product's previous owner agreed to, the Federal Trade Commission said Jan. 4 when it announced a record $3.2 million fine against the consumer healthcare giant
BBB National Programs’ appeals panel decision “includes factual and substantive inaccuracies, is not in accordance with NARB procedures, and misstates Colgate’s positions and arguments,” Colgate says. Panel upheld findings agreeing with P&G’s challenge of “removes 10 years of yellow stains” claim.